Innolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases to improve the life of patients around the world. Innolake was co-founded by two industry veterans, Dr. Mingde Xia (former Sr. Director of Global External Innovation at Johnson & Johnson) and Mr. Robert Chen (former founding member and Executive Vice President of Genor Biopharma, one of pioneering therapeutic antibody companies in China) in 2020. The company debuted with a top-tier and enthusiastic scientific & clinical development team and $40 million Series Pre-A. By continuously building proprietary technology platforms and R&D capabilities, Innolake places innovation at the cornerstone of its overall strategy. Through in-house R&D and partnering with MNCs and overseas biotech companies, Innolake has established a robust pipeline with more than ten first-in-class and best-in-class drug candidates, two of which have entered the clinical stage. Recently, Innolake was recognized as a “Chinese Next Unicorn” enterprise and listed on ”2021 China Biopharmaceutical Industry Innovation Top100 List”.
Company Details
- Employees
- 5
- Founded
- -
- Address
- New Bund World Trade Center Iii, No. 11, Lane 221, Dongyu Road, Shanghai,200126,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.innolakebio.com
- Keywords
- biotech, Oncology, autoimmune.
- HQ
- Shanghai
Innolake Biopharm Questions
Innolake Biopharm's website is http://www.innolakebio.com
Innolake Biopharm's LinkedIn profile is https://cn.linkedin.com/company/innolake-biopharm
Innolake Biopharm has
5 employees.
View email and phone details for 5
employees at Innolake Biopharm.
Innolake Biopharm's industry is
Pharmaceutical Manufacturing
Innolake Biopharm's top competitors are
Quantx Biosciences,
Cspc Pharmaceutical Group,
Inxmed 应世生物,
Visen Pharmaceuticals,
Recbio,
Innovent Biologics,
Duality Biologics,
Asieris Pharmaceuticals,
Forestown Global,
Eluminex Biosciences Limited.
Innolake Biopharm's categories are Pharmaceutical Manufacturing
Innolake Biopharm's founding year is 2020
